Judy Walczak - Concepedia

Author

Judy Walczak

Fox Chase Cancer Center

Also Known As

J R Walczak, J Walczak, Judy Walczak

Publications

336

Citations

H-Index

Concepts

All Affiliations

Fox Chase Cancer Center

About

Judy Walczak is an author at Fox Chase Cancer Center specializing in medicine, cancer therapeutics, and cancer research.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	224
2	Pharmacology	4	4	224
3	Cancer Therapeutics	4	4	224
4	Pathology	2	2	115
5	Clinical Pharmacology	1	1	85

Judy Walczak

Publications

316

Citations

H-Index

Page 1

	Year	Citations
Phase II study of biochemical modulation of fluorouracil by low-dose PALA in patients with colorectal cancer. Peter J. O’Dwyer, Angela Paul, Judy Walczak, Journal of Clinical Oncology Tumor BiologyOncologyGastrointestinal OncologyMedicineColorectal Cancer	1990	99
Phase I/pharmacokinetic study of topotecan by 24-hour continuous infusion weekly. Naomi B. Haas, F P LaCreta, Judy Walczak, PubMed Pharmaceutical Science24-Hour Continuous InfusionOncologyPharmacokinetic ModelingPhase Ii Evaluation	1994	85
Phase I trial and pharmacologic trial of sequences of paclitaxel and topotecan in previously treated ovarian epithelial malignancies: a Gynecologic Oncology Group study. Séamus O’Reilly, Gini F. Fleming, Shannon Barker, Journal of Clinical Oncology	1997	64
Phase II trial of PALA in combination with 5-fluorouracil in advanced pancreatic cancer Elizabeth Rosyold, Russell J. Schilder, Judy Walczak, Cancer Chemotherapy and Pharmacology OncologyPhase Ii TrialGastrointestinal OncologyPancreatic CancerMedicine	1992	24
Phase I Trial Of Fluorouracil Modulation by N-Phosphonacety-L-aspartate and 6-Methylmercaptopurine Riboside: Optimization of 6-Methylmercaptopurine Riboside Dose and Schedule Through Biochemical Analysis of Sequential Tumor Biopsy Specimens Peter J. O’Dwyer, GaryR. Hudes, Joseph Colofiore, JNCI Journal of the National Cancer Institute	1991	17
Phase I and pharmacokinetic study of the novel platinum analogue CI-973 on a 5-daily dose schedule. Peter J. O’Dwyer, Gary R. Hudes, Judy Walczak, PubMed Hematological Malignancy5-Daily Dose ScheduleTherapeutic Drug MonitoringOncologyMedicine	1992	16
Pharmacokinetic study of trimetrexate in combination with cisplatin. Gary R. Hudes, Frank LaCreta, Judy Walczak, PubMed	1991	11

Page 1